Murali Krishna Addepalli,Deborah H. Charych,Seema Kantak,Steven Robert Lee
申请号：
US15997487
公开号：
US20180344810A1
申请日:
2018.06.04
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to (among other things) a method of administering to a patient suffering from a cancer, the method comprising the steps of: (a) administering an IL-2Rβ-activating amount of a long acting, IL-2Rβ-selective agonist； and (b) administering a CTLA-4 pathway-inhibiting amount of an anti-CTLA-4 antibody or a PD-1 pathway-inhibiting amount of an anti-PD-1 antibody.
